2/7/25 16:19  | 2/5/25  | TECX | Tectonic Therapeutic, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | MA | O | CFO | P | 250 | 54.14 | 0 | 5 | New | 5 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/2/21 17:49  | 11/1/21  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 99 | 11.51 | 0 | 9 | 17 | 58 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/7/21 08:03  | 9/2/21  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 86 | 11.51 | 0 | 8 | 18 | 50 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/29/21 17:05  | 7/28/21  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 86 | 11.51 | 0 | 8 | 22 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/26/21 19:50  | 2/24/21  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 105 | 11.51 | 0 | 9 | 36 | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/28/20 18:12  | 9/25/20  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 46 | 11.51 | 0 | 4 | 39 | 14 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/20 18:18  | 8/11/20  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.a | 46 | 11.51 | 0 | 4 | 63 | 10 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/12/20 20:32  | 8/11/20  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | M.d | 46 | 11.51 | 0 | 4 | New | 4 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/5/19 06:08  | 11/4/19  | OYST | Oyster Point Pharma, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lochner Daniel | NJ | O | CFO | P | 101 | 16.00 | 0 | 6 | New | 6 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |